Prelude Statements
PR
Data from Prelude`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Sep, 2024
Next reporting period:
29 Dec, 2024
Report frequency:
Quarterly
Earnings release date:
06 Nov, 2024
Expected release date:
13 Feb, 2025
Prelude Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
3
—
100
—
0
—
—
0
29.457
981.9
7.919
264
37.376
0.6 %
1245.9
-34.376
7.5 %
-1145.9
—
0
2.105
70.2
-32.271
7.1 %
-1075.7
—
0
-32.271
7.1 %
-1075.7
-0.425
75.856
—
—
100
—
0
—
—
0
29.509
0
7.655
0
37.164
8.2 %
0
-37.164
-8.2 %
0
—
0
2.424
0
-34.74
-10.5 %
0
—
0
-34.74
-10.5 %
0
-0.459
75.762
—
—
100
—
0
—
—
0
27.409
0
6.934
0
34.343
-8.1 %
0
-34.343
8.1 %
0
—
0
2.912
0
-31.431
5 %
0
—
0
-31.431
5 %
0
-0.415
75.736
—
—
100
—
0
—
—
0
30.332
0
7.047
0
37.379
11.9 %
0
-37.379
-11.9 %
0
—
0
4.304
0
-33.075
-8.1 %
0
—
0
-33.075
-8.1 %
0
-0.475
69.592
—
—
100
—
0
—
—
0
26.26
0
7.12
0
33.39
3.1 %
0
-33.39
-3.1 %
0
—
0
2.78
0
-30.61
-0.6 %
0
—
0
-30.61
-0.6 %
0
-0.45
67.64
—
—
100
—
0
—
—
0
24.97
0
7.43
0
32.4
11.3 %
0
-32.4
-11.3 %
0
—
0
1.97
0
-30.43
-9.8 %
0
—
0
-30.43
-9.8 %
0
-0.54
56.24
—
—
100
—
0
—
—
0
21.83
0
7.28
0
29.12
-12.8 %
0
-29.12
12.8 %
0
—
0
1.4
0
-27.72
3.2 %
0
—
0
-27.72
3.2 %
0
-0.58
47.74
—
—
100
—
0
—
—
0
25.87
0
7.52
0
33.39
9.8 %
0
-33.39
-9.8 %
0
—
0
4.74
0
-28.64
4.4 %
0
—
0
-28.64
4.4 %
0
-0.6
47.69
—
—
100
—
0
—
—
0
22.89
0
7.52
0
30.41
3.2 %
0
-30.41
-3.2 %
0
—
0
0.45
0
-29.96
-9.5 %
0
—
0
-29.96
-9.5 %
0
-0.63
47.45
—
—
100
—
0
—
—
0
21.31
0
8.15
0
29.46
-2.7 %
0
-29.46
2.7 %
0
—
0
2.09
0
-27.37
7.1 %
0
—
0
-27.37
7.1 %
0
-0.58
47.28
—
—
100
—
0
—
—
0
22.82
0
7.47
0
30.29
-8.2 %
0
-30.29
8.2 %
0
—
0
0.82
0
-29.47
10.3 %
0
—
0
-29.47
10.3 %
0
-0.63
47.07
—
—
100
—
0
—
—
0
25.18
0
7.83
0
33.01
7 %
0
-33.01
-7 %
0
—
0
0.17
0
-32.84
-7 %
0
—
0
-32.84
-7 %
0
-0.7
46.68
—
—
100
—
0
—
—
0
22.72
0
8.12
0
30.84
10.5 %
0
-30.84
-10.5 %
0
—
0
0.15
0
-30.69
-14.2 %
0
—
0
-30.69
-14.2 %
0
-0.66
46.33
—
—
100
—
0
—
—
0
22.41
0
5.51
0
27.92
27.1 %
0
-27.92
-27.1 %
0
—
0
1.06
0
-26.87
-26.2 %
0
—
0
-26.87
-26.2 %
0
-0.58
46.06
—
—
100
—
0
—
—
0
16.47
0
5.5
0
21.97
13 %
0
-21.97
-13 %
0
—
0
0.67
0
-21.3
-10.6 %
0
—
0
-21.3
-10.6 %
0
-0.47
45.12
—
—
100
—
0
—
—
0
14.57
0
4.87
0
19.45
7.2 %
0
-19.45
-7.2 %
0
—
0
0.2
0
-19.25
-14.9 %
0
—
0
-19.25
-14.9 %
0
-0.52
37.1
—
—
100
—
0
—
—
0
15.29
0
2.85
0
18.14
-14.3 %
0
-18.14
14.3 %
0
—
0
1.38
0
-16.76
19.9 %
0
—
0
-16.76
19.9 %
0
-3.92
4.27
—
—
100
—
0
—
—
0
18.312
0
2.861
0
21.173
109.6 %
0
-21.173
-109.6 %
0
—
0
0.254
0
-20.919
-108.4 %
0
—
0
-20.919
-108.4 %
0
-4.899
4.27
—
—
100
—
0
—
—
0
8.85
0
1.25
0
10.1
—
0
-10.1
—
0
—
0
0.06
0
-10.04
—
0
—
0
-10.04
—
0
-2.35
4.27